This link will lead you to leave the website of Chugai Pharma Taiwan; the content of the linked website you choose (links, changes, or updates in this website) is no longer the responsibility of Chugai Pharma Taiwan. Chugai Pharma Taiwan does not take any legal responsibility for the information transmitted by this linked website.
This link is for your convenience only, and any link does not mean that Chugai Pharma Taiwan endorses or approves its website content.
Announcement
Read More
2023.04.01Top News
Mr. Takashi Okamoto assumes the President of Chugai Pharma Taiwan
Learn More
2019.10.01
Mr. Henry Chen assumes the president of Chugai Pharma Taiwan
Learn More
2019.02.01
CPT 30th Anniversary Celebration Donation to Eden Foundation fulfilling social responsibility
Learn More
2018.12.10
CPT 30th Anniversary Celebration
Learn More
2017.02.27
Chugai’s ALK Inhibitor “Alecensa®” Approved in Taiwan
Learn More
2016.02.05
Office Relocation of New CPT
Learn More
2015.10.01
Mr. Yoshimasa Saito assumes the president of Chugai Pharma Taiwan
Learn More
2015.07.31
Merger of Chugai Pharma Taiwan and Chugai Pharma R&D Taiwan